Press Releases

Capital Rx and Vida Health Partner to Launch Rx Activate, a High-Touch Chronic Condition Management Program

November 14, 2023

Capital Rx

  • Rx Activate leverages JUDI®, Capital Rx’s proprietary enterprise health platform, and Vida’s virtual cardiometabolic solutions to help plan sponsors manage and control costs related to chronic conditions in their populations

NEW YORK, Nov. 14, 2023/PRNewswire/ -- Capital Rx, the full-service pharmacy benefit manager (PBM) and pharmacy benefit administrator (PBA) advancing our nation's healthcare infrastructure to improve drug price visibility and patient outcomes, is partnering with Vida Health to launch Rx Activate and provide its clients with access to additional resources and options to help manage cardiometabolic conditions via personalized virtual care.  

With chronic conditions driving over $3.6 trillion in total healthcare expenditures in the U.S., it’s hard to ignore the problem plan sponsors face. Employer-funded health plans cover nearly two-thirds of workers in America.1 And it’s no secret that the treatment of cardiometabolic-based chronic conditions tends to drive stop-loss reimbursements, which can push premiums up in subsequent years. Capital Rx and Vida are addressing some fundamental gaps in care with a formulary- and benefit-aligned program: Rx Activate includes high-touch medication management supported by exceptional member service to build trust with providers and patients and help bring down the total cost of care.

“The ability to leverage JUDI®, a purpose-built enterprise health platform, to connect data sources, share information in real-time with stakeholders, and streamline workflows such as prior authorization, is a step forward in care delivery,” said Sara Izadi, PharmD, Chief Clinical Officer at Capital Rx. “Combining JUDI with Vida’s solutions for several of the most prevalent chronic conditions provides employers, municipalities, health plans, and other payers with a way to rein in and control their plan spend.”  

How the Capital Rx & Vida Partnership Aims to Bring Value to Clients

Plan members would have access to Vida’s providers and resources for cardiometabolic conditions, including hyperlipidemia, hypertension, diabetes, congestive heart failure, and weight management. Mental health support for depression and anxiety, which often accompany these conditions, is also provided.  

Plan sponsors and administrators can choose from three Rx Activate options, which include devices, labs, and medication prescribing, as needed:

  1. Rx Activate Standard focuses on the prevention and management of chronic conditions, including hypertension, hyperlipidemia, prediabetes and diabetes, COPD, and asthma, among others;
  1. Rx Activate, Obesity Step Solution, is for higher-acuity members and includes step-up-step-down prescribing of medications for weight management such as GLP-1s, behavior change therapy, medical nutrition therapy, and streamlined prior authorization (i.e., gold carding); and
  1. Rx Activate+, which includes everything covered by Rx Activate Standard and the Obesity Step Solution.

“Vida and Capital Rx share several goals, not least of which is to empower plan members to take control of their health and guide them toward improved outcomes, whether it be weight management, blood pressure control, diabetes care, or co-occurring socioeconomic and mental health factors,” said Richard Frank, Chief Medical Officer for Vida Health. “With the ability to seamlessly exchange information with Capital Rx via JUDI for the full range of conditions for which we have proven clinical outcomes, and those we may strive to tackle in the future, we clearly see the potential power of integrating our systems to provide whole-person care and improve healthcare affordability.”

Together, JUDI and Vida’s digital tools can offer chronic condition management and high-touch cardiometabolic care that delivers equitable health outcomes, addressing members regardless of socioeconomic status. Vida offers 25+ different cultural diets, full Spanish capabilities, food insecurity interventions, as well as tools to manage social isolation and emotional eating.  

To learn more about Rx Activate, please contact us.

About Vida Health

Vida Health is a virtual cardiometabolic clinic focused on treating diabetes and obesity with a body and mind approach. Vida’s clinically validated programs combine an AI-powered, personalized mobile app experience with a national network of high-quality providers who work in a high-touch care team model that maximizes engagement, outcomes, and savings. Vida’s app offers video sessions, asynchronous messaging, and digital content and programs to help people prevent and manage chronic conditions — like diabetes, obesity, and hypertension — and the mental conditions that accompany them — like stress, depression, and anxiety. Some of America’s largest employers and health plans trust Vida to deliver meaningful cardiometabolic outcomes for whole populations. Learn more at  

About Capital Rx

Capital Rx is a healthcare technology company advancing our nation’s electronic healthcare infrastructure to improve drug price visibility and patient outcomes. As a Certified B Corp™, the company is executing its mission through the deployment of JUDI®, Capital Rx’s cloud-native enterprise health platform, and an efficient Single-Ledger Model™, which increases visibility and reduces variability in drug prices. JUDI connects every aspect of the pharmacy ecosystem in one platform, servicing over 2.4 million members for Medicare, Medicaid, and commercial plans. Together with its clients, Capital Rx is reimagining the administration of pharmacy benefits and rebuilding trust in healthcare. To learn more, visit 

Media Contacts – Capital Rx

Michael Passanante, SVP, Marketing & Communications

Justin Venneri, Director, Communications

Media Contact – Vida Health

Connor Jones, Director, PR & Communications

1 2023 Employer Health Benefits Survey. KFF, 10/18/2023.

DOWNLOAD NOWBack to Insights

Sign up for our newsletter!

Get the latest information on JUDI news, webinars, and industry insights through our newsletter. Sign up now!